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AbstrACt
background: Ad hoc percutaneous coronary intervention (PCI) 
has proven to be safe in certain subsets of patients and the 
number of procedures has grown steadily over the years. In 
face of the scarcity of literature publications, we performed a 
comparative analysis of in-hospital outcomes of ad hoc and 
elective PCIs. Methods: From 2006 to 2010, 4,957 consecu-
tive patients were submitted to PCI and were included  in the 
Hospital Bandeirantes Registry. Patients undergoing primary or 
rescue PCI were excluded and of the remaining 4,048 patients, 
1,510 (37.3%) were submitted to ad hoc PCI and 2,538 to 
elective PCI. results: The ad hoc PCI group was younger, had 
a lower prevalence of comorbidities and a greater number 
of patients were treated in the presence of acute coronary 
syndrome. They exhibited less complex coronary lesions, used 
larger diameter stents and had more transient flow impair-
ments during PCI. Procedure success was similar between 
groups (97% vs. 96.8%; P = 0.70) as well as the occurrence 
of death (0.5% vs. 0.3%; P = 0.19), myocardial infarction 
(1.3% vs. 1.8%; P = 0.17), emergency coronary artery bypass 
graft surgery (0.4% vs. 0.2%; P = 0.36), stroke (0.1% vs. 0; 
P = 0.71) and major vascular complications (0.3% vs. 0.4%; 
P = 0.64). Conclusions: Ad hoc PCI is performed in lower risk 
patients and the outcomes demonstrate it is a safe procedure 
for most of the selected patients. 
DEsCrIPtOrs: Angioplasty. Stents. Time factors.
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rEsUMO
resultados Hospitalares da Intervenção  
Coronária Percutânea Ad Hoc vs. Eletiva
Introdução: A realização de intervenções coronárias percutâneas 
(ICPs) ad hoc tem mostrado ser segura em certos subgrupos 
de pacientes e o número de procedimentos tem aumentado 
progressivamente ao longo dos anos. Diante da escassez de 
estudos na literatura, realizamos análise comparativa dos re 
sultados hospitalares das ICPs ad hoc e eletiva. Métodos: No 
período de 2006 a 2010, 4.957 pacientes consecutivos fo ram 
submetidos a ICP e incluídos no Registro do Hospital Bandeirantes. 
Foram excluídos os pacientes submetidos a ICP primária ou de 
resgate, restando 4.048 pacientes, 1.510 (37,3%) submetidos 
a ICP ad hoc e 2.538, a ICP eletiva. resultados: O grupo ICP 
ad hoc mostrou ser mais jovem, com menor prevalência de 
comorbidades e maior número de pacientes tratados na vigência 
da síndrome coronária aguda. Mostraram ter menor gravidade 
angiográfica, utilizaram stents de maior diâmetro e apresentaram 
mais distúrbios de fluxo transitórios durante a ICP. O sucesso do 
procedimento foi semelhante entre os grupos (97% vs. 96,8%; 
P = 0,70), assim como a ocorrência de óbito (0,5% vs. 0,3%; 
P = 0,19), infarto do miocárdio (1,3% vs. 1,8%; P = 0,17), 
revascularização miocárdica de emergência (0,4% vs. 0,2%; 
P = 0,36), acidente vascular cerebral (0,1% vs. 0; P = 0,71) e 
complicações vasculares maiores (0,3% vs. 0,4%; P = 0,64). 
Conclusões: A ICP ad hoc é realizada em pacientes de menor 
risco e seus resultados demonstram que é um procedimento 
seguro para a maioria dos pacientes selecionados.
DEsCrItOrEs: Angioplastia. Stents. Fatores de tempo.
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the expression ad hoc is of Latin origin, and its literal translation is “for this” or “for this purpose”.1,2 In interventional cardiology, this 
expression has been used to define percutaneous 
coronary intervention (PCI) performed immediately 
after coronary angiography.
The use of PCI in the treatment of coronary heart 
disease is well established and is increasing.3 In the 
United States, the number of PCIs increased from 
400,000 procedures performed in 2000 to 1,265,000 
in the year 2005.4 Over the past two decades, there 
has been a proportionally significant increase in the 
number of ad hoc PCIs worldwide.1,5 Rahman et al.5 
report that during a ten-year period (1990 to 2000), 
the occurrence of these interventions increased from 
54% to 88%, and had less significant complica-
tion rates. These data are similar to those from the 
State of New York registry, where 80% of the PCIs 
are ad hoc.6
The use of ad hoc PCI has been frequent in Brazil. 
The procedure is safe compared with elective PCI in 
selected cases,7 and it is more comfortable for the 
patient, since it prevents additional procedures and 
brings a potential reduction in the rate of vascular 
complications at the puncture site.7-10 However, some 
disadvantages have been reported, such as increased 
exposure to radiation, a greater volume of contrast 
used (and therefore a greater chance of developing 
contrast-induced nephropathy), increased procedure 
time, difficulty in obtaining informed consent for 
the therapeutic procedure, and pressure for faster 
decision-making that compromises the concept of 
the “heart team”.7-10
Considering the advantages and disadvantages of 
ad hoc PCI and the scarcity of studies in our country, 
a comparative analysis of in-hospital outcomes of elec-
tive vs. ad hoc PCIs was performed.
Methods
Patients
From August 2006 to November 2010, 4,957 
consecutive patients undergoing PCI were included 
in the Hospital Bandeirantes registry (São Paulo, SP, 
Brazil). Patients undergoing primary or rescue PCI were 
excluded, leaving a total of 4,048 patients, of whom 
1,510 (37.3%) were submitted to ad hoc and 2,538, 
to elective PCI. Data were collected prospectively and 
stored in an electronic database. Clinical outcomes 
were recorded at hospital discharge.
PCI
The PCIs were performed (almost entirely) via femoral 
access, and the radial approach was employed in a few 
cases. The choice of the material and technique used 
during the procedure, as well as decisions regarding 
the use of glycoprotein IIb/IIIa inhibitors, were at the 
surgeon’s discretion. Unfractionated heparin was used 
at the beginning of the procedure at a dose of 70 U/kg 
and 100 U/kg, except in patients who were already 
using low-molecular weight heparin.
All patients received combined antiplatelet therapy 
with acetylsalicylic acid (ASA, a loading dose of 300 
mg and a maintenance dose of 100 mg/day to 200 
mg/day), and clopidogrel (with a loading dose of 300 
mg to 600 mg and a maintenance dose of 75 mg/day). 
The femoral sheaths were removed four hours after the 
start of heparinization. The radial sheaths were removed 
immediately after the procedure.
Angiographic analysis and definitions
Analyses were performed using at least two 
orthogonal projections by professionals who had ex-
perience with quantitative coronary angiography. This 
study used the same angiographic criteria as listed in 
the database of the National Center of Cardiovascular 
Intervention (Central Nacional de Intervenção Cardio-
vascular – CENIC) of Brazilian Society of Interventional 
Cardiology.11 The type of lesion was classified accord-
ing to the criteria of American College of Cardiology 
and American Heart Association (ACC/AHA).12 The 
Thrombolysis in Myocardial Infarction (TIMI) classifica-
tion was used to determine coronary flow prior to and 
after the procedure.13 Procedural success was defined 
as angiographic success achievement (residual stenosis 
< 30% with TIMI 3 flow) and the absence of major 
adverse cardiac or cerebrovascular events including 
death from any cause, myocardial infarction, stroke, 
or emergency CABG surgery.14
Myocardial infarction was indicated by the presence 
of new ischemic EKG alterations and/or alterations in 
laboratory markers of myocardial necrosis three-fold 
above the upper normal value and/or angiographic 
evidence of target vessel occlusion. Emergency CABG 
surgery was considered when performed immediately 
after the PCI.
statistical analysis
The data stored in the Oracle-based database were 
plotted in Excel spreadsheets and were analyzed using 
the SPSS, release 15.0. Continuous variables were 
expressed as means ± standard deviation, and cate-
gorical variables were expressed as absolute numbers 
and percentages. The associations between continuous 
variables were evaluated using an analysis of variance 
(ANOVA). Associations between categorical variables 
were evaluated using the chi-square or Fisher’s exact test 
or likelihood ratio when appropriate. The significance 
level was set at P <  0.05.
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The clinical characteristics are shown in Table 1. 
The ad hoc PCI group was on average one year younger 
(61.4 ± 12.1 years vs. 62.8 ± 11.5 years; P < 0.01) and 
had a lower prevalence of risk factors for atherosclero-
sis, with the exception of smoking (26.8% vs. 19.3%; 
P < 0.01). This group also had a lower prevalence of 
previous revascularization procedures (percutaneous 
12.1% vs. 21.9%; P < 0.01; surgical 8.3% vs. 14.6%; 
P = 0.02), as well as a lower prevalence of comorbidi-
ties such as myocardial infarction (17.7% vs. 20.8%; 
P = 0.02) or chronic renal failure (1.9% vs. 3.1%; 
P = 0.02). Regarding clinical presentation, a greater 
number of the patients in the ad hoc PCI group were 
treated in the evolved phase of myocardial infarction 
(21.5% vs. 7.1%) or were treated in the presence of 
non-ST-elevation acute coronary syndrome (20.4% vs.% 
11). Regarding the pre-procedure pharmacotherapy, 
the ad hoc PCI group had more patients receiving 
ASA (90.6% vs. 76.5%; P < 0.01), clopidogrel (73.9% 
vs. 64.2%; P < 0.01), and statins (71.9% vs. 60.6%, 
P  <  0.01). Glycoprotein IIb / IIIa inhibitors were also 
more frequently used in the ad hoc PCI group (6.3% 
vs. 2.7%; P = 0.03).
As presented in Table 2, the ad hoc PCI group had 
fewer severe patients, who also had a lower preva-
lence of three-vessel disease (10.6% vs. 15.8%) or left 
ventricular dysfunction (20.6% vs. 24.7%; P < 0.01). 
However, type B2/C lesions were more frequently 
treated in this group (57% vs. 52.1%; P < 0.01). The 
left anterior descending artery was the most frequently 
approached vessel in both groups (45.6% vs. 44%). 
Regarding the characteristics of the procedures (Table 
2), the ad hoc PCI group had stents that were larger 
in diameter (2.99 ± 0.46 mm vs. 2.91 ± 0.48 mm), but 
were of equal length to those implanted in the elective 
table 1 
Clinical characteristics
Ad hoc PCI Elective PCI P-value
Age (years) 61.4 ± 12.1 62.8 ± 11.5 < 0,01
Male gender, n (%) 1,036 (68.6) 1,702 (67.8) 0.58
Arterial hypertension, n (%) 1,107 (73.3) 1,942 (76.5) 0.02
Dyslipidemia, n (%) 480 (31.8) 948 (37.4) < 0.01
Diabetes mellitus, n (%) 403 (26.7) 819 (32.3) < 0.01
Smoking, n (%) 405 (26.8) 489 (19.3) < 0.01
Previous MI, n (%) 267 (17.7) 527 (20.8) 0.02
Previous PCI, n (%) 183 (12.1) 556 (21.9) < 0.01
Previous CABG, n (%) 125 (8.3) 370 (14.6) < 0.01
Previous stroke, n (%) 43 (2.8) 66 (2.6) 0.63
Chronic renal failure, n (%) 28 (1.9) 79 (3.1) 0.02
Clinical picture < 0.01
Asymptomatic 530 (35.1) 836 (34)
Ischemic equivalent 106 (17) 166 (6.5)
Stable angina 242 (16.1) 1,049 (41.4)
Recent MI 324 (21.5) 181 (7.1)
NSTE-ACS 308 (20.4) 279 (11)
Pre-procedural drug therapy
ASA 1,368 (90.6) 1,941 (76.5) < 0.01
Clopidogrel 115 (73.9) 1,629 (64.2) < 0.01
Statins 1,085 (71.9) 1,538 (60.6) < 0.01
Glycoprotein IIb/IIIa inhibitors 95 (6.3) 69 (2.7) 0.03
MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; NSTE-ACS, non-ST-elevation 
acute coronary syndrome; ASA, acetylsalicylic acid.
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PCI group (18 ± 6.7 mm vs. 18.2 ± 7.2 mm; P = 0.38). 
In the ad hoc PCI group, aspiration catheters were more 
frequently used (1.6% vs. 0.1%; P < 0.01), and transient 
flow disturbances occurred more frequently (no reflow 
and slow reflow) (2.4% vs. 0.7%; P < 0.01) during the 
PCI. Procedural success was similar between the groups 
(97% vs. 96.8%; P = 0.70).
Regarding hospital clinical outcomes (Table 3), 
there was no significant difference between groups 
regarding the incidence of death (0.5% vs. 0.3%; 
P = 0.19), myocardial infarction (1.3% vs. 1.8%; P = 0.17), 
emergency CABG (0.4% vs. 0.2%; P = 0.36), or stroke 
(0.1% vs. 0; P = 0.71). The incidence of major vascular 
complications was also similar between the groups 
(0.3% vs. 0.4%; P = 0.64).
dIsCussIon
PCI following the angiographic diagnostic proce-
dure (ad hoc PCI) had limitations until two decades 
ago, due to the unavailability of digital technology for 
image acquisition and the need for surgical backup 
with a surgical center available for all procedures at 
all times. With the development of image acquisition, 
guide and catheter technology, and especially stents 
and dual antiplatelet therapy, the need for emergency 
surgeries lessened significantly, and the number of ad 
hoc procedures over the past two decades has increased.
In the present registry, ad hoc procedures account 
for little more than one third of the total PCIs. When 
compared with other studies,8 this low rate can be ex-
plained by the difficulty in justifying costs (particularly 
in the supplementary private health care) regarding the 
need for PCI following the diagnostic procedure in 
patients with a stable clinical condition. In the pre sent 
registry, most patients undergoing ad hoc PCI had acute 
coronary syndrome or had a history of recent myocar-
dial infarction, as opposed to the elective PCI group 
patients who primarily had stable angina.
table 2 
Angiographic and procedural characteristics
Ad hoc PCI
(n = 1,510 patients/ 
1,784 lesions)
Elective PCI
(n = 2,538 patients/ 
3,315 lesions) P-value
Affected vessels, n (%) < 0.01
One 877 (58,1) 1,340 (52.8)
Two 449 (29.8) 738 (29.1)
Three 160 (10.6) 401 (15.8)
Left ventricular dysfunction, n (%) 273 (20.6) 248 (24.7) < 0.01
Treated vessel, n (%) 0.08
ADA 651 (45.6) 1,072 (44)
RCA 527 (36.9) 875 (35.9)
Cx 244 (171) 467 (19.2)
LMCA 5 (0.4) 22 (0.9)
Type B2/C lesions 1,081 (57) 1,727 (52.1) < 0.01
Stent diameter, mm 2.99 ± 0.46 2.91 ± 0.48 < 0.01
Stent length, mm 18 ± 6.7 18.2 ± 7.2 0.38
Aspiration catheter use, n (%) 25 (1.6) 4 (0.1) < 0.01
Transient no/slow reflow, n (%) 44 (2.4) 24 (0.7) < 0.01
Degree of stenosis, %
Pre-procedural 85.8 84.2 0.72
Post-procedural 1.4 1.5 0.34
Procedural success, n (%) 1,465 (97) 2,457 (96.8) 0.70
PCI, percutaneous coronary intervention; ADA, anterior descending artery; RCA, right coronary artery; Cx, circumflex artery; LMCA, left 
main coronary artery.
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Similarly, since a higher percentage of antiplatelet 
agents prior to the ad hoc procedure was indica-
tive of the patient’s condition, this factor facilitated 
decision-making in favor of the intervention following 
the coronary angiography.
The presence of multivessel disease was a factor 
against the performance of ad hoc PCI, which had a 
higher number of single-vessel patients. Single-vessel 
disease is an angiographic characteristic more commonly 
found in younger patients and smokers.16
There were no significant differences between the 
two groups regarding in-hospital clinical outcomes. 
In the American College of Cardiology-National Car-
diovascular Data Registry (ACC-NCDR), in the period 
between 2001 and 2003, 60.6% of the patients who 
underwent ad hoc PCI also showed no differences bet-
ween those who were electively treated for the occur-
rence of death, renal failure, or vascular complications 
during hospitalization.8 In another analysis of the New 
York registry, Hannan et al.6 assessed 46,565 PCIs that 
were performed between 2003 and 2005, and found 
no differences regarding in-hospital mortality between 
the ad hoc and elective PCI groups. At the three-year 
follow-up, however, the ad hoc PCI group had a lower 
mortality rate.
study limitations
The limitations of the present study include the 
retrospective analysis of data, its performance in a single 
center, and the absence of late follow-up.
ConClusIons
The present results demonstrate that ad hoc PCI 
should be performed in patients with lower risks and 
is safe for most selected patients.
ConflICt of InteRest
The authors declare no conflicts of interest.
Despite increased patient comfort, the performance 
of ad hoc PCI in stable patients can become a difficult 
or even inappropriate decision: in cases of unprotected 
trunk lesions or multivessel disease, in which the 
guidelines emphasize the need for the participation of 
clinicians and surgeons in therapeutic decision-making 
(the “heart team”); when there is a significant likelihood 
of exceeding the maximum doses of ionizing radiation 
or contrast media; when there are doubts regarding the 
effective use of optimized drug therapy or quantifica-
tion of ischemia in non-invasive tests; and in cases 
where there is no informed consent from the patient 
regarding the procedure that will follow the diagnostic 
coronary angiography. These and other aspects have 
been addressed in the recent publication of a consen-
sus by the Society for Cardiovascular Angiography and 
Interventions (SCAI).15
In the present registry, patients undergoing elective 
PCI were older and showed higher clinical comple-
xity. The possibility of complications resulting from 
a greater amount of contrast and a longer procedure 
likely assis ted in the selection of more severe patients 
for this group. These findings (previously reported by 
Goldstein et al.)10 demonstrated that patients undergoing 
ad hoc PCI had fewer comorbidities. The in-hospital 
mortality rates did not differ between the ad hoc and 
non-ad hoc groups (odds ratio [OR] 1.14; P = 0.38) 
but were more significant in the ad hoc PCI group in 
the presence of comorbidities such as congestive heart 
failure or class IV stable angina.
Although the patients in the ad hoc PCI group had 
fewer comorbidities, as well as clinical characteristics 
that were more favorable for procedure performance, 
negative effects such as type B2/C lesions, the pre-
sence of flow disturbances, and the need for the 
use of aspiration catheters and glycoprotein IIb/IIIa 
inhibitors were more frequently observed in this group. 
This finding may be explained by the increased 
number of patients with acute coronary syndrome 






(n = 2,538) P-value
Death, n(%) 8 (0.5) 7 (0.3) 0.19
MI, n (%) 19 (1.3) 46 (1.8) 0.17
Emergencial CABG, n (%) 5 (0.4) 4 (0.2) 0.36
Previous stroke, n (%) 1 (0.1) 0 0.71
Higher vascular complication, n (%) 5 (0.3) 10 (0.4) 0.64
PCI, percutaneous coronary intervention; MI, myocardial infarction; CABG, coronary artery bypass graft.
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